State-Dependent Blocking Actions of Azimilide Dihydrochlo-ride (NE-10064) on Human Cardiac Na+ Channels-Reference-Cited by-同舟云学术

State-Dependent Blocking Actions of Azimilide Dihydrochlo-ride (NE-10064) on Human Cardiac Na+ Channels

Published:2004 Issue:7 Volume:68 Page:703-711
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Miake Junichiro¹,Kurata Yasutaka²,Iizuka Kazuhiko¹,Furuichi Hitomi³,Manabe Kasumi³,Sasaki Norihito³,Yamamoto Yasutaka³,Hoshikawa Yoshiko³,Taniguchi Shin-ichi¹,Yoshida Akio¹,Igawa Osamu¹,Makita Naomasa⁴,Shiota Goshi⁵,Nanba Eiji⁶,Ohgi Shigetsugu⁷,Narahashi Toshio⁸,Hisatome Ichiro³

Affiliation:

1. Department of Cardiovascular Medicine, Tottori University Hospital

2. Department of Physiology, Kanazawa Medical University

3. Division of Regenerative Medicine and Therapeutics, Department of Gene Therapy and Regenerative Medicine, Institute of Regenerative Medicine and Biofunction, Tottori University Graduate School of Medical Science

4. Department of Cardiovascular Medicine, Hokkaido University Graduate School of Medicine

5. Division of Gene Therapy, Department of Gene Therapy and Regenerative Medicine, Institute of Regenerative Medicine and Biofunction, Tottori University Graduate School of Medical Science

6. Gene Research Center, Tottori University

7. Department of Cardiovascular Surgery, Tottori University Hospital

8. Department of Molecular Pharmacology and Biological Chemistry, Northwestern University Medical School

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

http://www.jstage.jst.go.jp/article/circj/68/7/68_7_703/_pdf

Reference30 articles.

1. The Novel Class III Antiarrhythmics NE-10064 and NE-10133 Inhibit Isk Channels Expressed in Xenopus Oocytes and Iks in Guinea Pig Cardiac Myocytes

2. Use-Dependent Effects of the Class III Antiarrhythmic Agent NE-10064 (Azimilide) on Cardiac Repolarization

3. Pharmacology of Azimilide Dihydrochloride (NE-10064), A Class III Antiarrhythmic Agent

4. Efficacy of the Class III Antiarrhythmic Agent Azimilide in Rodent Models of Ventricular Arrhythmia

5. Suppression of Inducible Ventricular Arrhythmias by Intravenous Azimilide in Dogs with Previous Myocardial Infarction

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CSAHi study-2: Validation of multi-electrode array systems (MEA60/2100) for prediction of drug-induced proarrhythmia using human iPS cell-derived cardiomyocytes: Assessment of reference compounds and comparison with non-clinical studies and clinical information;Regulatory Toxicology and Pharmacology;2017-08

2. Enhancing effects of salicylate on quinidine-induced block of human wild type and LQT3 related mutant cardiac Na+ channels;Biomedical Research;2011